Vascular Specialist International
Table. 2.

Table. 2.

Health outcomes of participants according to ABI categoriesa during the follow-up period

Health outcomes Patients with ab-ABI (n=33) Patients with nl-ABI (n=252) P-valueb
MACEc
Yes 20 (60.6) 87 (34.5) 0.0036
No 13 (39.4) 165 (65.5)
Disease progressiond
Yes 16 (48.5) 79 (31.3) 0.0496
No 17 (51.5) 173 (68.7)
Repeated revascularizatione
Yes 11 (33.3) 33 (13.1) 0.0025
No 22 (66.7) 219 (86.9)
All-cause mortality
Yes 6 (18.2) 17 (6.7) 0.0233
No 27 (81.8) 235 (93.3)

Values are presented as number (%).

ABI, ankle-brachial index; ab-ABI, abnormal ABI; nl-ABI, normal ABI; MACE, major adverse cardiac events.

aABI categories were defined as ab-ABI (<1.0 or >1.4) and nl-ABI (1.0≤ABI≤1.4). bP-value was determined using the chi-square test. cMACE included disease progression, repeated revascularization, and all-cause mortality. dDisease progression was defined as stenosis >30% or occlusion of any coronary artery on the latest coronary angiography. eRepeated revascularization was defined as stenosis >50% on coronary angiography or stenosis <50% with a correlated symptom.

Vasc Specialist Int 2020;36:89~95 https://doi.org/10.5758/vsi.200012
© Vasc Specialist Int
© The Korean Society for Vascular Surgery. Powered by INFOrang Co., Ltd